Começar
Libratus

NVAX- Dark horse in the vaccine race

Viés de alta
Novavax, Inc. (NASDAQ:NVAX)  
Libratus  
NASDAQ:NVAX   Novavax, Inc.
Trend Analysis Volume Fundamental Analysis fundamental-analysis vaccines newtrend Fibonacci Retracement reversesplit insider-selling atthemarket
2
0
trendanalysis volumestudies fundamental fundamental-analysis vaccines newtrend fibonacciretracement reversesplit insider-selling atthemarket
No one can predict the result of NVAX's phase 3 trial. However, I don't count out any potential winners in the vaccine race even though now it seems very likely that NVAX won't be the first one to distribute vaccines at massive scale.

That being said, as long as the result of phase 3 trial isn't a complete failure, I think the crowd frenzy will keep pushing NVAX's price up.

To be on the safe side, I would market buy 33% of my overall position and limit buy the remaining in the demand zone.

Just my opinion. Not the investment advice.

Ideias Relacionadas

Libratus
MRNA- Leader in the vaccine race. Ladder buy to avoid the risk
Aviso legal

As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.